These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 15841951)

  • 41. Homocysteine in postmenopausal women and the importance of hormone replacement therapy.
    Mijatovic V; van der Mooren MJ
    Clin Chem Lab Med; 2001 Aug; 39(8):764-7. PubMed ID: 11592448
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Long-term prevention with hormone-replacement therapy after the menopause: which women should be targeted?
    Alexandersen P; Karsdal MA; Christiansen C
    Womens Health (Lond); 2009 Nov; 5(6):637-47. PubMed ID: 19863467
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Osteoporosis and hormone replacement therapy].
    Roux C
    Presse Med; 2005 Mar; 34(5):379-84. PubMed ID: 15859575
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Osteoporosis and cardiovascular disease: benefit-risk of hormone replacement therapy.
    Sammartino A; Cirillo D; Mandato VD; Di Carlo C; Nappi C
    J Endocrinol Invest; 2005; 28(10 Suppl):80-4. PubMed ID: 16550729
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Has the impact of hormone replacement therapy on health-related quality of life been undervalued?
    Tosteson AN; Gabriel SE; Kneeland TS; Moncur MM; Manganiello PD; Schiff I; Ettinger B; Melton LJ
    J Womens Health Gend Based Med; 2000 Mar; 9(2):119-30. PubMed ID: 10746515
    [TBL] [Abstract][Full Text] [Related]  

  • 46. The Controversial History of Hormone Replacement Therapy.
    Cagnacci A; Venier M
    Medicina (Kaunas); 2019 Sep; 55(9):. PubMed ID: 31540401
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Climacteric medicine: European Menopause and Andropause Society (EMAS) 2004/2005 position statements on peri- and postmenopausal hormone replacement therapy.
    Skouby SO; Al-Azzawi F; Barlow D; Calaf-Alsina Erdogan Ertüngealp J; Gompel A; Graziottin A; Hudita D; Pines A; Rozenberg S; Samsioe G; Stevenson JC;
    Maturitas; 2005 May; 51(1):8-14. PubMed ID: 15883103
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Hormone replacement therapy in women with breast cancer. Do the risks outweigh the benefits?
    Roy JA; Sawka CA; Pritchard KI
    J Clin Oncol; 1996 Mar; 14(3):997-1006. PubMed ID: 8622051
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Hormone replacement therapy as primary prevention?].
    Eiken P; Vestergaard P; Jensen JE
    Ugeskr Laeger; 2014 Mar; 176(6):. PubMed ID: 25096207
    [TBL] [Abstract][Full Text] [Related]  

  • 50. The changing view of hormone replacement therapy.
    Vogel RA
    Rev Cardiovasc Med; 2003; 4(2):68-71. PubMed ID: 12776015
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Controversies over hormone replacement therapy. HRT as a risk factor of breast cancer in postmenopausal women.
    Licznerska BE; Baer-Dubowska W
    Acta Pol Pharm; 2005; 62(3):241-7. PubMed ID: 16193819
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Do perceptions of risk and quality of life affect use of hormone replacement therapy by postmenopausal women?
    Scheid DC; Coleman MT; Hamm RM
    J Am Board Fam Pract; 2003; 16(4):270-7. PubMed ID: 12949027
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Prognostic features of menopausal and postmenopausal applicants for life insurance.
    Schiefeling M
    J Insur Med; 1996; 28(1):27-34. PubMed ID: 10172866
    [TBL] [Abstract][Full Text] [Related]  

  • 54. The hormone replacement therapy controversy.
    Lumsden M
    BJOG; 2005 Jun; 112(6):689-91. PubMed ID: 15924520
    [No Abstract]   [Full Text] [Related]  

  • 55. Evidence from randomised trials on the long-term effects of hormone replacement therapy.
    Beral V; Banks E; Reeves G
    Lancet; 2002 Sep; 360(9337):942-4. PubMed ID: 12354487
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Menopause in 2004: "hormone replacement therapy" is not what it used to be anymore].
    Azoulay C
    Rev Med Interne; 2004 Nov; 25(11):806-15. PubMed ID: 15501350
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Hormone replacement therapies in women at risk of cardiovascular disease and osteoporosis in South Australia in 1997.
    MacLennan AH; Wilson DH; Taylor AW
    Med J Aust; 1999 Jun; 170(11):524-7. PubMed ID: 10397042
    [TBL] [Abstract][Full Text] [Related]  

  • 58. The Women's Health Initiative trial and related studies: 10 years later: a clinician's view.
    Gurney EP; Nachtigall MJ; Nachtigall LE; Naftolin F
    J Steroid Biochem Mol Biol; 2014 Jul; 142():4-11. PubMed ID: 24172877
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Benefits and challenges of hormone replacement therapy.
    Borgelt L; Umland E
    J Am Pharm Assoc (Wash); 2000; 40(5 Suppl 1):S30-1. PubMed ID: 11029858
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Consequenses for HRT following the HERS II and WHI reports: the primum non nocere is important, but translation into quo vadis is even more essential.
    Skouby S
    Acta Obstet Gynecol Scand; 2002 Sep; 81(9):793-8. PubMed ID: 12225293
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.